Literature DB >> 33189594

Clinical and Imaging Features of Non-Small-Cell Lung Cancer in Young Patients.

Sherief H Garrana1, Ibiayi Dagogo-Jack2, Rosemary Cobb2, Anderson H Kuo3, Dexter P Mendoza1, Eric W Zhang1, Allen Heeger1, Lecia V Sequist2, Subba R Digumarthy4.   

Abstract

BACKGROUND: Non-small-cell lung cancer (NSCLC) in young adult patients is rare, with scarce data available in patients aged < 40 years and even less in those aged < 35 years. Our goal was to determine the presenting symptoms, clinicopathologic characteristics, and imaging features of young patients with NSCLC at time of diagnosis and compare them to those of older adults. PATIENTS AND METHODS: We retrospectively analyzed the medical records and imaging of young patients (≤ 40 years old) with NSCLC treated at our institution between 1998 and 2018. Patients < 35 years old were compared to those between 35 and 40 years old. Characteristics of patients ≤ 40 years old were compared to older patients (> 40 years) from publicly available data sets.
RESULTS: We identified 166 young patients with NSCLC (median age, 36.6 years; range, 18-40 years). Most presented with nonspecific respiratory symptoms and were diagnosed with pneumonia (84/136, 62%). Compared to patients < 35 years old, patients 35-40 years old were more likely to have malignancy detected incidentally (15% vs. 5%, P = .04). Patients < 35 years old were more likely to have central tumors (55% vs. 33%, P = .02) and to have bone (38% vs. 19%, P = .007) and lung (39% vs. 24%, P = .03) metastases. Compared to older patients (> 40 years), young patients were more likely to be never smokers (65.0% vs. 14.7%, P < .001) and to have advanced disease (88% vs. 66%, P < .001).
CONCLUSION: Young patients with NSCLC often present with nonspecific symptoms and have advanced disease at diagnosis, often mimicking other pathologies. Awareness of the clinical presentation and imaging features of NSCLC in young patients may help minimize delays in diagnoses.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Imaging; Lung cancer; Oncogene; Radiology; Targeted therapy

Mesh:

Year:  2020        PMID: 33189594     DOI: 10.1016/j.cllc.2020.10.012

Source DB:  PubMed          Journal:  Clin Lung Cancer        ISSN: 1525-7304            Impact factor:   4.785


  6 in total

1.  Epidemiology and prognosis in young lung cancer patients aged under 45 years old in northern China.

Authors:  Jin Shi; Daojuan Li; Di Liang; Yutong He
Journal:  Sci Rep       Date:  2021-03-25       Impact factor: 4.379

2.  The significance of systematic lymph node dissection in surgery for early-stage non-small cell lung cancer patients aged ≤40 years.

Authors:  Zhi-Yi Guo; Jiang-Hao Ren; Yuan-Yuan Xu; Rui-Jun Liu; Hui Tao; Jia Huang; Qiang Tan
Journal:  J Thorac Dis       Date:  2021-02       Impact factor: 2.895

Review 3.  The role of psychiatry in quality of life in young patients with non-small cell lung cancer.

Authors:  Orna Alpert; Bakht Siddiqui; Zed Shabbir; Majd Soudan; Patrik Garren
Journal:  Brain Behav Immun Health       Date:  2022-09-07

4.  Age does matter in adolescents and young adults vs. older adults with lung adenocarcinoma: A retrospective analysis comparing clinical characteristics and outcomes in response to systematic treatments.

Authors:  Lin Zhou; Huiwu Li; Shuhui Yang
Journal:  Oncol Lett       Date:  2022-08-31       Impact factor: 3.111

5.  Small cell lung cancer in young patients: trends in sociodemographic factors, diagnosis, treatment, and survival.

Authors:  Umit Tapan; Kimberley S Mak; Michelle H Lee; Muhammad Mustafa Qureshi; Kei Suzuki; Peter Everett
Journal:  J Thorac Dis       Date:  2022-08       Impact factor: 3.005

Review 6.  Importance of tumor subtypes in cancer imaging.

Authors:  Ali Khader; Marta Braschi-Amirfarzan; Lacey J McIntosh; Babina Gosangi; Jeremy R Wortman; Christoph Wald; Richard Thomas
Journal:  Eur J Radiol Open       Date:  2022-07-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.